Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112613222 | 11261322 | 2 | F | 20150630 | 20160923 | 20150710 | 20160930 | EXP | ES-ASTELLAS-2015US024261 | ASTELLAS | 49.92 | YR | F | Y | 0.00000 | 20160930 | CN | GB | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
112613222 | 11261322 | 1 | PS | Erlotinib | ERLOTINIB | 1 | Oral | U | 21743 | 150 | MG | TABLET | QD | ||||||
112613222 | 11261322 | 2 | SS | Erlotinib | ERLOTINIB | 1 | Oral | U | 21743 | 100 | MG | TABLET | QD | ||||||
112613222 | 11261322 | 3 | SS | Erlotinib | ERLOTINIB | 1 | Oral | U | 21743 | 100 | MG | TABLET | QD | ||||||
112613222 | 11261322 | 4 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 1218 MG, ON DAY 1 OF 21 DAY CYCLE | Y | 0 | 1218 | MG | FORMULATION UNKNOWN | ||||||
112613222 | 11261322 | 5 | C | SUTRIL /01036501/ | TORSEMIDE | 1 | Oral | D | U | 0 | 5 | MG | FORMULATION UNKNOWN | ||||||
112613222 | 11261322 | 6 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 10, UNKNOWN FREQ. | D | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
112613222 | 11261322 | 1 | Non-small cell lung cancer |
112613222 | 11261322 | 4 | Non-small cell lung cancer |
112613222 | 11261322 | 5 | Product used for unknown indication |
112613222 | 11261322 | 6 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
112613222 | 11261322 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
112613222 | 11261322 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
112613222 | 11261322 | 1 | 20130613 | 0 | ||
112613222 | 11261322 | 2 | 20150629 | 0 | ||
112613222 | 11261322 | 3 | 20160830 | 0 | ||
112613222 | 11261322 | 4 | 20130613 | 0 | ||
112613222 | 11261322 | 5 | 20150630 | 0 | ||
112613222 | 11261322 | 6 | 20160831 | 0 |